Subclinical thyroid dysfunction does not affect one-year mortality in elderly patients after hip fracture: a...

Area of Science:

• Gerontology
• Endocrinology
• Trauma Surgery

Background:

• Mortality following hip fractures is a critical outcome measure in elderly patients.
• Subclinical thyroid dysfunction is prevalent in the elderly population.
• Investigating the impact of thyroid dysfunction on mortality in this vulnerable group is essential.

Purpose of the Study:

• To determine the prevalence of subclinical thyroid dysfunction in elderly hip fracture patients.
• To assess the association between subclinical thyroid dysfunction and one-year mortality.
• To identify factors influencing mortality in this cohort.

Main Methods:

• Prospective study of 131 elderly hip fracture patients (mean age 82.0 years).
• Assessed prevalence of subclinical hypothyroidism (TSH > 5.5 mU/L) and hyperthyroidism (TSH < 0.35 mU/L).
• Used logistic regression to analyze factors associated with 12-month mortality, including thyroid status.

Main Results:

• 18% of patients had subclinical thyroid dysfunction (15% hypothyroidism, 3% hyperthyroidism).
• Overall 12-month mortality was 27%.
• Only ASA grade significantly affected mortality; subclinical thyroid dysfunction did not.

Conclusions:

• Subclinical thyroid dysfunction is common in elderly hip fracture patients.
• Subclinical thyroid dysfunction is not independently associated with increased one-year mortality.
• Surgical management of hip fractures in the elderly requires consideration of comorbidities like ASA grade for mortality risk.